Atlas Trials

Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD)

Clinical trial NCT04391959 · COMPLETED

Trial details

NCT number
NCT04391959
Sponsor
Azura Ophthalmics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Meibomian Gland Dysfunction
Start date
2020-07-17
Primary completion
2021-01-06
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.